4.7 Article

Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders

期刊

MOLECULAR PHARMACEUTICS
卷 16, 期 10, 页码 4165-4180

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.9b00496

关键词

particle engineering; biopharmaceutical; pulmonary drug delivery; spray freeze-drying; spray drying; dispersibility

资金

  1. Amgen Inc.
  2. American Association of Pharmaceutical Scientists Foundation
  3. National Heart, Lung, and Blood Institute of the National Institutes of Health [F31HL146178]

向作者/读者索取更多资源

Pulmonary delivery of biopharmaceuticals may enable targeted local therapeutic effect and noninvasive systemic administration. Dry powder inhaler (DPI) delivery is an established patient-friendly approach for delivering large molecules to the lungs; however, the complexities of balancing protein stability with aerosol performance require that the design space of biopharmaceutical DPI formulations is rigorously explored. Utilizing four rationally selected formulations obtained using identical atomization conditions, an extensive study of the effect of the particle formation process (spray drying or spray freeze-drying) on powder properties, aerosol performance, and protein stability was performed. Multiple linear regression analysis was used to understand the relationship between powder properties, device dispersion mechanism, and aerosol performance. Spray drying and spray freeze-drying, despite the same spraying conditions, produced powders with vastly different physical characteristics, though similar aerosol performance. The resulting regression model points to the significance of particle size, density, and surface properties on the resulting aerosol performance, with these factors weighing differently according to the device dispersion mechanism utilized (shear-based or impaction-based). The physical properties of the produced spray dried and spray freeze-dried powders have differing implications for long-term stability, which will be explored extensively in a future study.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Inhaled fixed-dose combination powders for the treatment of respiratory infections

Ashlee D. Brunaugh, Shivam Sharma, Hugh Smyth

Summary: Inhaled fixed-dose combination powders (I-FDCs) offer a promising approach for the treatment of respiratory infections by enabling simultaneous drug delivery at the site of infection. The use of co-spray drying shows potential for the development of composite anti-infective particles for inhalation. Future research may focus on including immunomodulatory agents or repurposed non-antibiotics in fixed-dose combinations.

EXPERT OPINION ON DRUG DELIVERY (2021)

Article Multidisciplinary Sciences

Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae

Ashlee D. Brunaugh, Hyojong Seo, Zachary Warnken, Li Ding, Sang Heui Seo, Hugh D. C. Smyth

Summary: The co-formulation of Niclosamide with human lysozyme enables the direct aerosol delivery of the drug to the respiratory tract, effectively treating COVID-19 by targeting the primary site of virus acquisition and spread. The novel formulation demonstrates potent activity against various coronavirus strains and may offer protection against secondary inflammatory lung damage, with low-cost development approach ensuring rapid clinical development and widespread utilization.

PLOS ONE (2021)

Article Chemistry, Medicinal

Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder

Ashlee D. Brunaugh, Li Ding, Tian Wu, Michael Schneider, Ryan Khalaf, Hugh D. C. Smyth

Summary: Monoclonal antibody-based therapies have the potential to be a valuable treatment modality for acute and chronic lung diseases. Direct delivery to the lungs via inhalation can provide higher drug concentrations at the site of disease with reduced off-target effects. However, there is limited understanding of the impact of particle engineering processes on the stability and performance of dry powder inhaler formulations of monoclonal antibodies.

JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Review Pharmacology & Pharmacy

A Quality by Design Framework for Capsule-Based Dry Powder Inhalers

Li Ding, Ashlee D. Brunaugh, Sven Stegemann, Scott V. Jermain, Matthew J. Herpin, Justin Kalafat, Hugh D. C. Smyth

Summary: This review aims to provide information on critical factors to be considered for the development of capsule-based dry powder inhalers (cDPIs) using a quality by design (QbD) approach. Defining critical quality attributes is essential in order to understand critical material attributes and critical process parameters.

PHARMACEUTICS (2021)

Article Pharmacology & Pharmacy

Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations

Li Ding, Ashlee D. Brunaugh, Rishi Thakkar, Christian Lee, Qingyan Jenny Zhao, Justin Kalafat, Mohammed Maniruzzaman, Hugh D. C. Smyth

Summary: This study investigates the impact of different types of capsules on the aerosol performance of two DPI formulations. In carrier-based formulations, the capsule type does not significantly affect performance. However, for carrier-free formulations, there are some differences between capsule types.

AAPS PHARMSCITECH (2022)

Article Pharmacology & Pharmacy

Nebulization of a polyelectrolyte-drug system for systemic hypertension treatment

Nazareth E. Ceschan, Sebastian Scioli-Montoto, Maria Laura Sbaraglini, Maria Esperanza Ruiz, Hugh D. C. Smyth, Veronica Bucala, Maria Ramirez-Rigo

Summary: Hypertension is a chronic condition that can cause organ damage and cardiovascular diseases. Atenolol, a commonly used drug for hypertension and arrhythmia, has low oral bioavailability. This study proposes an alternative inhalatory system for Atenolol, which uses a spray-dried ion complex to release the drug. Experimental results showed that the system has good drug release performance and potential for cardiac targeting.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Review Pharmacology & Pharmacy

Mixing of dry powders for inhalation: A review

Jamie E. Spahn, Feng Zhang, Hugh D. C. Smyth

Summary: This article provides a comprehensive overview of the extensive application of solids mixing in the pharmaceutical science, with a focus on the key factors of ordered mixing in the preparation of dry powder inhalers.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Article Microbiology

Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection

Ashlee D. Brunaugh, Amanda Walz, Zachary Warnken, Camron Pearce, Juan Munoz Gutierrez, John J. Koleng, Hugh D. C. Smyth, Mercedes Gonzalez-Juarrero

Summary: Tuberculosis (TB) is a major disease in low- and middle-income countries. Inhaled drug delivery is a promising method for achieving high drug concentrations at infection sites. This study found that delivering drugs through the lungs can lead to faster bactericidal activity and that the infection status and administration route can affect drug pharmacokinetics. Additionally, the study showed that the formulation produced by air jet milling is stable during storage and aerosol performance.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Pharmacology & Pharmacy

Development of a novel method for the continuous blending of carrier-based dry powders for inhalation using a co-rotating twin-screw extruder

Jamie E. Spahn, Amr Hefnawy, Hugh D. C. Smyth, Feng Zhang

Summary: This study assessed the feasibility of using twin-screw extruders as mixers for dry powder inhalation and found that they can effectively function as mixers for inhalable powders, thus enhancing the continuous manufacturing capability of dry powder inhalers.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Article Chemistry, Medicinal

Twin-Screw Continuous Mixing Can Produce Dry Powder Inhalation Mixtures for Pulmonary Delivery

Angela Ren, John J. Koleng III, Mark Costello, Jamie E. Spahn, Hugh D. C. Smyth, Feng Zhang

Summary: The feasibility of using a twin-screw corotating extruder as a continuous process mixer for preparing dry powder inhalation (DPI) powders was investigated. The study compared the performance of twin-screw mixing with low and high-shear batch mixing methods. The results showed that twin-screw mixing produced homogeneous mixtures with aerosol performance comparable to high-shear batch mixing, and the particles had similar morphology to both low and high-shear batch mixing.

JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Article Pharmacology & Pharmacy

Design Validation of a Smart Inhaler Device with an Integrated Spacer for Enhanced Aerosolization Performance

Amr Hefnawy, Matthew J. Herpin, Michael Easton, Shrinidh Joshi, Don Jordan, Hugh D. C. Smyth, Jonathan Tarpy

Summary: This article reports the development and optimization of the ARI(TM) smart pMDI inhaler device with integrated spacer functionality. The design was optimized using simulations and validated through in vitro experiments. The results show that the ARI(TM) device, with its converging-diverging nozzle design, improves airflow and enhances the mixing between inhalation air and the propellent jet, leading to better aerosol performance compared to the unmodified Symbicort inhaler and the OptiChamber spacer.

JOURNAL OF PHARMACEUTICAL INNOVATION (2023)

Article Pharmacology & Pharmacy

Development of low-cost, weight-adjustable clofazimine mini-tablets for treatment of tuberculosis in pediatrics

Zachary Warnken, Andrea Trementozzi, Patricia P. Martins, Jagruti Parekh, John J. Koleng, Hugh D. C. Smyth, Ashlee Brunaugh

Summary: Clofazimine (CFZ) is an essential part of the World Health Organization's (WHO) recommended treatment for multi-drug resistant tuberculosis (MDR-TB). However, the lack of a dividable oral dosage form limits its use in pediatric populations. In this study, pediatric-friendly CFZ mini-tablets were prepared and showed promising results in terms of rapid disintegration and dissolution. Pharmacokinetic tests in rats demonstrated no significant difference between the mini-tablets and oral suspension, providing a proof-of-concept for an alternative, cost-effective oral delivery for CFZ in young children.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Article Chemistry, Analytical

The Importance Complete Overlapping of Analyte and Internal Standard Peaks in Eliminating Matrix Effects with Liquid Chromatography-Mass Spectrometry (LC-MS)

Amitha K. Hewavitharana, P. Nicholas Shaw, H. D. C. Smyth, L. P. Samaranayake, H. M. H. N. Bandara

Summary: The study found that the use of stable isotope-labeled analogues as internal standards for matrix effects correction in LC-MS is most effective when the analyte and internal standard peaks completely overlap. Measuring the coelution degree between analytes and internal standards can help reduce data scatter and improve the accuracy of the analysis results.

LC GC NORTH AMERICA (2021)

暂无数据